Researchers used a cross-vaccination strategy in the trial, which involved 33 healthy adult volunteers between the ages of 21 and 45.
The work explains how lipocartilage cells form and preserve their own lipid reservoirs while maintaining a consistent size.
Scientists created new medications to suppress PD-1 and activate the body’s immune system to combat cancer after its discovery.
Researchers have developed a new method to detect more contagious forms of bacteria or viruses that transmit to people, such as those that cause TB, whooping cough, COVID, and the flu.
In addition to confirming viral methyltransferases as a viable therapeutic target, the results imply that Tuschl’s specific inhibitor would have few adverse effects.
Research into the genomes of malaria parasites opens the door to more potent, novel therapies.
It is anticipated that this novel approach to creating ionizable lipids will have significant effects on mRNA-based vaccines and treatments, which are positioned to address a variety of illnesses, including infectious diseases and genetic abnormalities.
A team of researchers from Kyushu University has created a novel antibody that targets and inhibits the malfunction of the protein hepatocyte growth factor, or HGF, which is essential for developing, regenerating, and repairing skeletal muscle.
A class of tumors known as soft tissue sarcoma of the extremities develops in the muscles, tendons, fat, blood vessels, or nerves of the arms and leg
In 2022–2023, the researchers found people diagnosed with obesity without diabetes using a nationwide sample of medical insurance claims data from over 17 million persons with private insurance.
